In vitro susceptibility testing procedures for fosfomycin tromethamine.

AUTOR(ES)

Barry, A L

RESUMO

Fosfomycin tromethamine (previously fosfomycin trometamol) is an orally administered fosfomycin which may be used for single-dose therapy of uncomplicated urinary tract infections. Fosfomycin tromethamine, norfloxacin, and trimethoprim-sulfamethoxazole inhibited greater than 90% of 352 bacterial isolates representing 25 different species; trimethoprim and nalidixic acid had narrower spectrums of activity. Strains of Escherichia, Citrobacter, Enterobacter, and Klebsiella species were much more susceptible when glucose-6-phosphate was added to the test medium, but isolates belonging to other genera were not affected.

Documentos Relacionados

• Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults.
• In vitro chloramphenicol susceptibility testing of Haemophilus influenzae: disk diffusion procedures and assays for chloramphenicol acetyltransferase.
• In Vitro Chloramphenicol Susceptibility Testing of Haemophilus influenzae: Disk Diffusion Procedures and Assays for Chloramphenicol Acetyltransferase
• Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
• In Vitro Susceptibility Testing with Tobramycin